Medicare Part D
What’s new in the Medicare landscape for 2021?
Medicare Advantage plans are available for people with End-Stage Renal Disease (ESRD) as of 2021. Medical Advantage plans have the flexibility to include telehealth provider in practice areas including primary care, cardiology, dermatology, psychiatry, gynecology, and endocrinology Standard Medicare Part D prescription drug plan coverage parameters are new in 2021. Initial Deductible will increase by […]
New CMS Medicare Advantage Rule Creates Incentives for Providers to Invest in Telehealth
The Centers for Medicare & Medicaid Services (CMS) announced Friday it has finalized changes to Medicare Advantage (MA) and Medicare Part D. The changes — detailed in a final rule for 2021 — partly seek to strengthen access to telehealth services, an increasingly important component of the health care system amid the ongoing coronavirus emergency. While the […]
CMS expands telehealth options for Medicare Advantage plans
A final rule published by the Centers for Medicare and Medicaid Services on Friday would allows Medicare Advantage plans to cover more specialties through telehealth. By ELISE REUTER Post a comment / May 22, 2020 at 4:41 PM The Centers for Medicare and Medicaid Services (CMS) will allow Medicare Advantage plans to cover a wider range of telehealth […]
CMS Finalizes Telehealth Reimbursement for MA Plans, ESRD Patients
The Centers for Medicare & Medicaid Services has issued a final rule on expanded telehealth coverage for members in Medicare Advantage plans and those living with end-stage renal disease. By Eric Wicklund May 22, 2020 – The Centers for Medicare & Medicaid Services is finalizing plans to expand telehealth coverage in Medicaid Advantage plans. Building on a proposed rule […]
CMS Flexibilities to Fight COVID-19 – Medicare Advantage and Part D Plans
Medicare Advantage and Part D Plans: CMS Flexibilities to Fight COVID-19 Since the beginning of the COVID-19 Public Health Emergency, the Trump Administration has issued an unprecedented array of temporary regulatory waivers and new rules to equip the American healthcare system with maximum flexibility to respond to the 2019 Novel Coronavirus (COVID-19) pandemic. These temporary […]